Big Data Methods for Comprehensive Similarity based Risk Prediction
Big Data Methods for Comprehensive Similarity based Risk Prediction
批准号:
10323033
负责人:
KRZYSZTOF KIRYLUK
金额:
$45.57万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-12 至 2024-01-31
关键词:
AddressAutomationBig DataBig Data MethodsBiological MarkersBiological ProcessBiometryCase StudyCharacteristicsChronicChronic DiseaseChronic Kidney FailureClassificationClinicalClinical DataClinical MedicineComplexDataData ReportingData ScienceDerivation procedureDiagnosisDiseaseDisease ProgressionElectronic Health RecordEnd stage renal failureEnvironmentEtiologyExhibitsExposure toGeneticGenomicsGoalsHealthHealth ProfessionalHealthcareHeterogeneityHumanIndividualInformaticsInterdisciplinary StudyInterventionKnowledgeLengthLifeLiteratureMachine LearningMedicalMedical GeneticsMedical RecordsMethodsModelingNatural Language ProcessingOutcomePatientsPharmaceutical PreparationsPopulationPreparationReportingReproducibilityResearchRiskSocial EnvironmentSourceSurveysTechniquesbasebiomedical informaticsclinical decision supportclinical decision-makingclinical phenotypeclinical riskdata analysis pipelinedata modelingdata standardsdesigndisease diagnosisfeature selectionhealth dataimprovedinteroperabilitymortality risknovelopen dataopen sourceoutcome predictionpatient health informationpatient populationprecision medicinepredict clinical outcomerisk predictionsocioeconomicssupport toolsvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Electronic health records (EHR) provide rich source of data about representative populations and are yet to be
fully utilized to enhance clinical decision-making. Conventional approaches in clinical decision-making start
with the identification of relevant biomarkers based on subject-matter knowledge, followed by detailed but
limited analysis using these biomarkers exclusively. As the current scientific literature indicates, many human
disorders share a complex etiological basis and exhibit correlated disease progression. Therefore, it is
desirable to use comprehensive patient data for patient similarity. This proposal focuses on deriving a
comprehensive and integrated score of patient similarity from complete patient characteristics currently
available, including but not limited to 1) demographic similarity; 2) genetic similarity; 3) clinical phenotype
similarity; 4) treatment similarity; and 5) exposome similarity (here exposome defined as all available attributes
of the living environment an individual is exposed to), when some of the aspects may overlap and interact. We
will optimize information fusion and task-dependent feature selection for assessing patient similarity for clinical
risk prediction. Since currently there does not exist a pipeline that is able to extract executable complete
patient determinant data, to achieve the research goal described above, we propose first deliver an open-
source data preparation pipeline that is based on a widely used clinical data standard, the OMOP
(Observational Medical Outcomes Partnership) Common Data Model (CMD) version 5.2. Moreover, to mitigate
common missingness and sparsity challenges in clinical data, we describe the first attempt to represent
patients' sparse clinical information with missingness, including diagnosis information, medication data,
treatment intervention, with a fixed-length feature vector (i.e. the Patient2Vec). This project has four specific
aims. Aim 1 is to develop a clinical data processing pipeline for harmonizing patient information from multiple
sources into a standards-based uniformed data representation and to evaluate its efficiency, interoperability,
and accuracy. Aim 2 is to leverage a powerful machine learning technique, Document2Vec, from the natural
language processing literature, to create an open-source Patient2Vec framework for the derivation of
informative numerical representations of patients. Aim 3 is to develop a unified machine learning clinical-
outcome-prediction framework for Optimized Patient Similarity Fusion (OptPSF) that integrates traditional
medical covariates with the derived numerical patient representations from Patient2Vec (Aim 2) for improved
clinical risk prediction. Aim 4 is to evaluate our similarity framework for predicting 1) the risk of end-stage
kidney disease (ESKD) in general EHR patient population and 2) the risk of death among patients with chronic
kidney disease (CKD).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-APOL1 genetic factors and kidney transplant outcomes
-
批准号:10717171
-
项目类别:
-
资助金额:$72.38万
-
财政年份:2023
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Multi-Omics for Chronic Kidney Disease
-
批准号:10744557
-
项目类别:
-
资助金额:$83.67万
-
财政年份:2023
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies
-
批准号:10438855
-
项目类别:
-
资助金额:$43.48万
-
财政年份:2020
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies
-
批准号:10251946
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2020
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies
-
批准号:10020606
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2020
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Big Data Methods for Comprehensive Similarity based Risk Prediction
-
批准号:10551349
-
项目类别:
-
资助金额:$45.57万
-
财政年份:2019
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Big Data Methods for Comprehensive Similarity based Risk Prediction
-
批准号:10087958
-
项目类别:
-
资助金额:$45.57万
-
财政年份:2019
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Genomics of glomerular disease
-
批准号:10203943
-
项目类别:
-
资助金额:$87.01万
-
财政年份:2018
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Genomics of glomerular disease
-
批准号:10413152
-
项目类别:
-
资助金额:$87.01万
-
财政年份:2018
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Genetics of IgA nephropathy by integrative network-based association studies
-
批准号:9258422
-
项目类别:
-
资助金额:$42.27万
-
财政年份:2015
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Genetics of IgA nephropathy by integrative network-based association studies
-
批准号:10660683
-
项目类别:
-
资助金额:$68.52万
-
财政年份:2015
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Genetics of IgA nephropathy by integrative network-based association studies
-
批准号:8863093
-
项目类别:
-
资助金额:$43.77万
-
财政年份:2015
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Population-based study of serum IgA, IgA1, and galactose-deficient IgA1 levels
-
批准号:8571130
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2013
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Population-based study of serum IgA, IgA1, and galactose-deficient IgA1 levels
-
批准号:8692756
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2013
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Quantitative Genetics of Defective IgA1 Glycosylation in IgA Nephropathy
-
批准号:8029111
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2011
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Quantitative Genetics of Defective IgA1 Glycosylation in IgA Nephropathy
-
批准号:8397657
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2011
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Quantitative Genetics of Defective IgA1 Glycosylation in IgA Nephropathy
-
批准号:8245696
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2011
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
Quantitative Genetics of Defective IgA1 Glycosylation in IgA Nephropathy
-
批准号:8596814
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2011
-
负责人:KRZYSZTOF KIRYLUK
-
依托单位:
海外基金